S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7119 +0.14%
AFTER HRS · 18:30 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

HLF

HERBALIFE LTD.
NYSE · HEALTH CARE · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
13.71
−0.06 −0.44%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.4BP/E 8.8DIV YIELD —FCF YIELD 22.43%REV TTM $5.2B +5.5%NET INCOME $164.2M −49.5%NET DEBT $1.6B52W 7.75 – 19.96SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$1.3B+5.4%77.7%$128.3M−$26.3M−153.3%-0.25$32.9M$11.3M$21.6MAug 5
Q1 2026 · Mar 31$1.3B+7.8%77.9%$138.4M$61.9M+22.8%0.57$113.8M$10.9M$102.9MMay 6
Q4 2025 · Dec 31derived$1.3B+6.3%77.5%$99.8M$85.4M−52.0%0.82$98.3M$18.5M$79.8MFeb 18
Q3 2025 · Sep 30$1.3B+2.7%77.7%$125.8M$43.2M−8.9%0.42$138.8M$20.8M$118MNov 5
Q2 2025 · Jun 30$1.3B−1.7%78.0%$132.6M$49.3M+948.9%0.48$96M$22.8M$73.2MAug 5
Q1 2025 · Mar 31$1.2B−3.4%78.3%$122.8M$50.4M+107.4%0.49$200K$18.3M−$18.1MMay 6
Q4 2024 · Dec 31derived$1.2B−0.6%77.8%$106.5M$177.9M+1644.1%1.75$69.6M$25.7M$43.9MFeb 18
Q3 2024 · Sep 30$1.2B−3.2%78.3%$127.1M$47.4M+10.7%0.46$99.5M$27.1M$72.4MNov 5
Q2 2024 · Jun 30$1.3B—77.9%$80.4M$4.7M—0.05$102.5M$36.3M$66.2MAug 6
Q1 2024 · Mar 31$1.3B—77.5%$71.9M$24.3M—0.24$13.8M$32.9M−$19.1MApr 30
Q4 2023 · Dec 31derived$1.2B—76.3%$55.8M$10.2M—0.10$96.1M$35.3M$60.8MFeb 18
Q3 2023 · Sep 30$1.3B—76.3%$106.7M$42.8M—0.43$79.6M$31.1M$48.5MOct 30

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$5B77.9%$481M$228.3M4.5%2.20$333.3M$80.4M$252.9M$8.2M—
FY2024 · to Dec 31$5B77.9%$385.9M$254.3M5.1%2.50$285.4M$122M$163.4M$8.3M—
FY2023 · to Dec 31$5.1B76.5%$356.4M$142.2M2.8%1.42$357.5M$135M$222.5M$11M—
FY2022 · to Dec 31$5.2B77.4%$545.2M$321.3M6.2%3.23$352.5M$156.4M$196.1M$146.7M—
FY2021 · to Dec 31$5.8B78.6%$734.1M$447.2M7.7%4.13$460.3M$151.4M$308.9M$1B—
FY2020 · to Dec 31$5.5B79.2%$640.6M$372.6M6.7%2.77$628.6M$112M$516.6M$923.5M—

Every number comes from HERBALIFE LTD.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch HLF. Know when insiders buy.
One email the day a filing lands. Free.